Regeneron Pharmaceuticals (REGN)
Operating Cash Flow
$4.44B
TTM · Period ending: · USD
REGN Operating Cash Flow
Latest reported$4.44Bperiod ending
Latest reported$4.44Bperiod ending
REGN TTM Operating Cash Flow (-$17.20M → $4.44B)
TTM operating cash flow
High-resolution chart · PNG
REGN operating cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| -25,749,000 | |
| -19,720,000 | |
| -27,910,000 | |
| -17,140,000 | |
| -20,636,000 | |
| -21,987,000 | |
| -13,800,000 | |
| -26,500,000 | |
| -14,600,000 | |
| -14,400,000 | |
| -10,200,000 | |
| -1,400,000 | |
| -7,300,000 | |
| -6,900,000 | |
| -6,100,000 | |
| -9,300,000 | |
| -14,600,000 | |
| -16,400,000 | |
| -20,300,000 | |
| -18,100,000 | |
| -22,400,000 | |
| -18,900,000 | |
| -18,200,000 | |
| -31,700,000 | |
| -26,300,000 | |
| -18,100,000 | |
| -20,500,000 | |
| -18,100,000 | |
| -18,200,000 | |
| -31,800,000 | |
| -30,100,000 | |
| -27,100,000 | |
| -24,900,000 | |
| -21,300,000 | |
| -17,200,000 | |
| -12,600,000 | |
| -11,500,000 |